Medical Affairs Executive Forum and the

13th Investigator-Initiated Trials Conference for Maximum Learning and Networking Opportunities!

Tri-Located with ExL Pharma’s

THE BUSINESS OF SCIENCEHoning MSL Business Acumen and Expertise to Drive Long-Term Corporate Sustainability and SuccessRALPH REWERS, PharmD, Executive Director and Head Regional Medical Liaisons,Scientific Affairs, AMGEN

INTERACTIVE SESSION: METRICS FOR MSLSWhere Are We Now and Where Are We Going?PETER PILIERO, MD, Executive Director and Medical Leader, BOEHRINGER INGELHEIM

MSLS AND CLINICAL TRIALSOutlining the Challenges and Opportunities for MSLs to Support the Successful Execution of Investigator-Initiated Trials and Company-Sponsored TrialsANNA KOZLOVSKI, PharmD, Associate Medical Director, Lymphoma Team Lead, EISAI

PRE-CONFERENCE WORKSHOP A:

MSL AND MEDICAL AFFAIRS COLLABORATIONImproving Internal Communication between Field-Based MSLs and Office-Based Medical Affairs to Strengthen Scientific Integrity and Therapeutic Area SuccessPAUL WEBER, MD, RPh, MBA, Executive Director, Global Medical Affairs, Medical Disease Lead, CELGENE

PRE-CONFERENCE WORKSHOP B:

MSL TRAINING STANDARDSDeveloping the Skills and Core Competencies of MSLs to Enhance Team PerformancePAUL MINNE, PharmD, RPH, Senior Regional Medical Liaison Metabolic Bone, AMGENDENISE PITNER, PharmD, Therapeutic Team Director, NOVARTISCRAIG KLINGER, RPh, Senior Medical Liaison Consultant, ELI LILLY & CO.

DISTINGUISHED SPEAKERS

JOIN US FROM:

ACTELION PHARMACEUTICALS, US

AMGEN

BAYER HEALTHCARE

BOEHRINGER INGELHEIM

CELGENE

ELI LILLY & CO.

EISAI

GENZYME

IKARIA

MCGUIREWOODS

NOVARTIS

OPENQ

SHIRE

WITHIN3

ZIPHER MEDICAL AFFAIRS, LLC

SPONSORED BY:

A P R I L 1 4 - 1 5 , 2 0 1 1 | D O L C E | B A S K I N G R I D G E | N E W J E R S E Y

8th MSL BEST PRACTICES

To Register Cal l 866-207- 6528 or Vis it www.exlpharma.com/8thmsl

WHO SHOULD ATTEND?Professionals from Pharmaceutical,

Biotechnology and Medical Device

companies with responsibilities in the

following areas:

• Medical Science Liaisons (MSLs, MLs)

• Medical Affairs

• Medical Communications

• Scientific Affairs

• Medical Advisors/Managers

• Clinical Trial Liaisons

• KOL Development

• Clinical Research

• Medical Education

• Clinical/Outcomes Liaisons

• Clinical Investigators

• Business Intelligence

• Regulatory Affairs

This conference is also of interest to:

• Software and Technology Companies

• Staffing Agencies/Recruiters

• Law Firms

• Consultants

DOLCE BASKING RIDGE300 NORTH MAPLE AVE BASKING RIDGE, NJ 07920

PHONE: 800-953-8033

FAX: 908-953-3105

Dolce Basking Ridge combines a retreat-like setting with over 20,000 square feet of IACC approved function space. The award-winning Dolce Basking Ridge is the Tri-state region’s setting of choice for business and pleasure. A recent multi-million dollar redesign has updated our accommodations, restaurantand lobby to have the chic and contemporary feel of New York City while maintaining the quiet seclusion of Basking Ridge.

Dolce Basking Ridge is less than an hour west of Manhattan from Interstate 287, 78 and 80.

Newark Liberty Airport is approximately a 30-minute drive, while LaGuardia and JFK Airports are just an hour away.

Shuttle Information: We offer Complimentary shuttle service within a 6 mile radius which includes the Basking Ridge Train Station.

Airport Information: Newark International Airport is approximately 30 minutes away.

Please contact the hotel directly at 800-953-8033 to book your room. Please mention ExL Pharma and the 8th MSL Best Practices conference to take advantage of this discount. You must book your room by March 23, 2011 to be eligible for the discounted rate. Please book your room early as the rooms available at this rate are limited and review your hotel confirmation to ensure that you received the ExL group rate.

“I was really impressed with virtually everything about this event. The topics were right on target, the speakers were great, having lots of time for questions and interactive discussions was perfect.”

– MEDICAL SCIENTIFIC MANAGER | ALLERGAN

Dear Colleague,As the healthcare landscape in the United States continues to change, the role of the Medical Science Liaison (MSL) is growing in relevance and importance. Stricter regulations, increased competition, and shrinking pipelines are contributing to higher stakes and the need for pharmaceutical, biotech and medical device companies to have effective MSL teams in place. The education and product awareness that MSLs bring to thought leaders and the broader medical community are essential to corporate sustainability and success. Further, the peer-to-peer relationships that MSLs initiate and maintain with KOLs and the field insights they bring back to the company are fundamental, particularly as sales forces are being reduced throughout the nation. The strong business acumen, communication skills, and therapeutic area expertise that MSLs possess are tools that are tremendously meaningful, and when channeled properly, can be enormously valuable to both internal and external stakeholders.

Building from the success of seven previous events, ExL Pharma’s 8th MSL Best Practices is designed to provide attendees with information on the latest trends, changes, and best practices for MSLs operating in such a complex environment. Attending this event provides exciting opportunities for networking with industry colleagues and benchmarking activities, strategies and goals. The expert speaking faculty and highly informative topics help MSLs effectively meet the needs of internal and external customers, while remaining professionally fulfilled.

We look forward to greeting you in April!

Sincerely,

Lindsay Slater Senior Conference Director 8th MSL Best Practices

“Exceeded my expectations” - MSL | TERCICA “Excellent seminar…will attend in the future” – MSL | MILLENNIUM

To Register Cal l 866-207- 6528 or Vis it www.exlpharma.com/8thmsl

PRE-CONFERENCE WORKSHOP | DAY ONE THURSDAY, APRIL 14

8:00 REGISTRATION AND CONTINENTAL BREAKFAST FOR WORKSHOP PARTICIPANTS

9:00 PRE-CONFERENCE WORKSHOP A: MSL AND MEDICAL AFFAIRS COLLABORATION Improving Internal Communication between Field-Based MSLs and Office-Based Medical Affairs to Strengthen Scientific Integrity and Therapeutic Area Success

• Definingexpectationstooptimizethecollaborationbetweenhomeofficeandfieldbasedteams

• UnderstandinghowMSLscaneffectivelyconveyimportantfieldmedicalinsightstoinformandpotentiallychangetheactivitiesofinternalMedicalAffairscolleagues

• Realizingthevalueofoffice-basedMedicalAffairsinsettingstrategy• SharingbestpracticesespeciallyregardingKOLinteractionsformaintainingthe

balanceofroles,responsibilities,andrelationshipsoffunctionalgroupswithinMedicalAffairs

• Leveragingthebenefitsofincreasedcommunicationandtransparency

* Thisworkshopwillbehighlyparticipatoryforattendees.Itsdesignwillincludebreakoutgroupsandreporting.Paul Weber, MD, RPh, MBA, Executive Director, Global Medical Affairs, Medical Disease Lead, CELGENE

10:30 NETWORKING & REFRESHMENT BREAK

12:00 WORKSHOP CONCLUDES; LUNCHEON FOR WORKSHOP PARTICIPANTS

9:00 PRE-CONFERENCE WORKSHOP B: MSL TRAINING STANDARDS Developing the Skills and Core Competencies of MSLs to Enhance Team Performance

• IdentifyingthekeyattributesessentialfortheMSLrole• Howcaninterpersonalskillsbeimproved,ifatall?• Weighingeducationandexperience–istherean“ideal”combination?Isone

moreimportantthantheother?• StrikingtherightcombinationofstrengthsacrossanMSLteam• Hiringatrainerandoutliningtherolesandresponsibilitiesoftheposition• Buildinginassessmenttoolsinhiringcriteria• MeasuringthesuccessofMSLtraininginitiatives

Paul Minne, PharmD, Senior Regional Medical Liaison, AMGEN Denise Pitner, PharmD, Therapeutic Team Director, NOVARTIS Craig Klinger, RPh, Senior Medical Liaison Consultant, ELI LILLY & CO.10:30 NETWORKING & REFRESHMENT BREAK

12:00 WORKSHOP CONCLUDES; LUNCHEON FOR WORKSHOP PARTICIPANTS

MAIN CONFERENCE BEGINS | DAY ONE

1:00 CHAIRPERSON’S WELCOME AND OPENING REMARKS Hilary D. Mandler, PharmD, Director, ADHD Medical Science Liaisons, SHIRE

1:15 THE BUSINESS OF SCIENCE

Honing MSL Business Acumen and Expertise to Drive Long-Term Corporate Sustainability and Success

• Exploringthepotentialoffield-basedmedicaltocompliantlystrengthenexistingrelationships,forgenewpartnershipsandserveaskeyplayersinstrategicplanninganddevelopment

• Acquiringandsynthesizingfieldinsightstodriveclinicalandcorporatedecision-making

• DemonstratingvalueoftheexpensiveMSLpositiontothecompany• Providingmaximumvaluetointernalteamsandexternalpartnersthrough

establishedcredibilityandexpertise Ralph Rewers, PharmD, Executive Director and Head Regional Medical Liaisons, Scientific Affairs, AMGEN

2:00 INTERACTIVE SESSION: METRICS FOR MSLS

Where Are We Now and Where Are We Going?

• Benchmarkingdata:whatistheindustrydoing?• Establishinggoalsandmeasuringperformancefordemonstratingvalueand

maximizingresults• Selectingcompliantmetricsthataremeaningfultomanagementandacceptedby

theMSLteam• Balancingqualitativeandquantitativemetricsthatreflectvaluetointernal

stakeholdersandexternalcustomers• Leveragingmetricsforteammotivationandmorale

Peter Piliero, MD, Executive Director & Medical Leader, BOEHRINGER INGELHEIM

2:45 NETWORKING AND REFRESHMENT BREAK

3:15 CASE STUDY

Maximizing MSL Productivity and Compliance through the Development of a Monthly Activity Reporting System

• Utilizingareportingsystemtostrengthencompliancewithinternalpoliciesandproceduresaswellasindustry-wideregulatoryrequirements

• Consideringthe“how,”the“why,”andthe“whyimportant”ofamonthlyactivityreportingsystemforMSLteams

• IncreasingcommunicationandtransparencybetweenMSLsandtheirmanageronactivities,reporting,andgoaltracking

• Exploringthebenefitsofimplementingatoolthatshowsresourceallocationandtheneedforexpansion,asitcantrackandreportontimeperactivity(perday,week,month,year)

• OptimizinginternalcommunicationtostrengthenMSL-KOLinteractions Peter L. Goldberg, PhD, Associate Director, Medical Science Liaisons, ACTELION PHARMACEUTICALS, US

4:00 FIELDING A WINNING TEAM Empowering MSLs to Maximize Your Return on Investment (ROI)

• DefiningasuccessfulMSLteam;reviewexamplesofMSLprogramsandanalyzingstrengthsandweaknessesinordertodemonstratesubtledifferencesbetweenagoodandanoutstandingMSLorganization

• Exploringtheroleseducation,decisionmakingandcommunicationplayinenhancingMSLperformance

• OutliningthetechniquesandsystemsthatcanbeimplementedtoimproveMSLperformance

• Discussingtheimportanceofdebriefing,measuringsuccessandhowKOLsreacttoempoweredMSLs

• Usinginternalcommunicationstodemonstratevalue Peg Crowley-Nowick, PhD, MBA, Founder and President, ZIPHER MEDICAL AFFAIRS, LLC

To Register Cal l 866-207- 6528 or Vis it www.exlpharma.com/8thmsl

4:45 COCKTAIL RECEPTION & ROUNDTABLE

DISCUSSIONS

CHOOSE YOUR PREFERRED TOPIC AND DISCUSS

IN AN INTIMATE, BREAK-OUT STYLE, SETTING.1. Team Size and Design:HowcanmyteambestallocateMSLs,resourcesand

activities?2. Aggregate Spend and Reporting Requirements:Howwill/arestateand

federaldisclosurelawsimpactingphysician-industryrelationships,andhowcanIensurethatmyinteractionswithHCPsarecompliant?

3. National KOLs:Whatarebestpracticesforidentifying,buildingandleveragingrelationshipswithnationalthoughtleaders?

4. MSL Team Management:Whatcanandshouldmanagersbedoingtoensurecohesive,motivatedandeffectiveteams?

5. Off-Label Information Dissemination:HowcanMSLsmitigateriskofviolatinglaws,rulesandcompanypolicieswhenrespondingtounsolicitedrequests?

6. Professional and Personal Development:WhatopportunitiesareavailableandhowcanMSLsmaintainfeelingfulfilledwhileintheircurrentpositionsandlookingtothefuture?

6:00 CLOSE OF DAY ONE

MAIN CONFERENCE | DAY TWOFRIDAY, APRIL 15

8:00 CONTINENTAL BREAKFAST FOR CONFERENCE PARTICIPANTS

8:45 CHAIRPERSON’S RECAP OF DAY ONE AND MODERATORS’ KEY POINTS FROM ROUNDTABLE DISCUSSIONS Hilary D. Mandler, PharmD, Director, ADHD Medical Science Liaisons, SHIRE

9:00 REGULATORY OVERVIEW Sunshine Provisions, Corporate Integrity Agreements, DOJ Investigations, Oh My!

• Outliningthe“SunshineAct”provisionsandtheirimpactonMSLactivities• DiscussingFDA/OIGconcernsaboutoff-labelpromotion• Exploringillustrativestatereportingrequirementsandrestrictionsonindustry-KOL

interactions• Examiningtheprevalenceofcorporateintegrityagreementsandtheireffecton

theMSLrole• Strategiestodecreasetheriskthatindividual,teamorcompanycouldbeaccused

ofviolations Joseph P. McMenamin, MD, JD, Partner, MCGUIREWOODS

10:00 COMPLIANT MSL-KOL ENGAGEMENT Regulatory and Technological Trends for 2011

•CompliantqualificationofKOLs•Techniquesforplanning,executing,andmeasuringanMSL/KOLstrategy•Gatheringfieldinsightsthroughresponsiveinquiry•Analyticsforensuringtheregulatorycomplianceandoperatingeffectivenessof

yourprograms Jim Zuffoletti, President and Co-Founder, OPENQ

10:45 NETWORKING AND REFRESHMENT BREAK

11:15 PANEL DISCUSSION: BREAKING DOWN SILOS Increasing Compliant Collaboration with Sales for Improved Transparency, Efficiency, and KOL Management

• Determiningthetypesofcommunicationthatareappropriateandbeneficial,andestablishingacompliantprocessforcross-functionalinteractions

• Exploringbestpracticesfordocumentinginformationexchangedbetweeninternaldepartments

• Overcomingbarrierstoworkingwithsalesanddemonstratingvaluetoyourcommercialcolleagues

• Realizingthepositivebusinessoutcomesofcompliantandcontrolledcommunicationacrossteams

Panelists: Douglas Werner, MBA, National Director, Oncology, Medical Science Liaisons, U.S. Medical Sciences, BAYER HEALTHCARE Ralph Rewers, PharmD, Executive Director and Head Regional Medical Liaisons, Scientific Affairs, AMGEN Cindy Sellers O’Brien, RN, BSN, MBA, Director, Medical Science Liaison Team–Solid Organ Transplant, GENZYME TRANSPLANT AND ONCOLOGY

12:00 DIGITAL KOL ENGAGEMENT Creating an Online Forum to Dramatically Increase Interactions with Important KOLs

Inthissession,participantswilllearnhowengaginginaprivate,onlinecommunitycan:• GalvanizerelationshipsandenhanceKOLinteractions• Providevaluableinsightsaswellascompletevisibilityintotherapeuticdiscussions• EnablemorefrequentHCPinteractionona24/7basisdespitegeographic

locations• FosteremergingKOLs

•ExpandreachandinteractionswithglobalKOLleaders Lance Hill, CEO, WITHIN3

12:45 LUNCHEON FOR CONFERENCE PARTICIPANTS

1:45 MSLS AND CLINICAL TRIALS

Outlining the Challenges and Opportunities for MSLs to Support the Successful Execution of Investigator- Initiated Trials and Company-Sponsored Trials

• EnhancingtherelationshipbetweenR&DandMedicalAffairstosupportefficienttrialimplementation

• ExploringtheidealapprovalflowofIITsfromMSLdiscussionofideaswithinvestigatorstodialoguewithregionalteams

• DetermininghowtheMSLcanhelpensurethattimelinesarebeingadheredtoandmilestonesarebeingmet

• EstablishingtherightlevelofMSLinvolvement,ifany,instudydesign,protocolandconduct

Anna Kozlovski, PharmD, Associate Medical Director, Lymphoma Team Lead, EISAI

2:30 LEADING FROM BELOW

How to Provide Leadership (and Increase One’s Value) within an Organization

Uponcompletionofthissessiontheattendeewillbeableto:• Describethedifferencebetweenamanagerandaleader• Recognizethequalitiescommontoleaders• Understandtheimportanceofleadersoninfluencingchangeandimproved

organizations• Developafoundationforacquiringthebehaviorsneededtoeffectivelyleadfrom

below Douglas Hansell, MSOM, RRT, Medical Science Liaison, IKARIA

3:15 CONFERENCE CONCLUDES

FIVE WAYS TO REGISTER PHONE: 866-207-6528

EMAIL: register@exlpharma.com

ONLINE: www.exlpharma.com

FAX: 888-221-6750

MAIL: ExL Events, Inc. 555 8th Ave, Ste 310 New York, NY 10018

GROUP DISCOUNT PROGRAM:

SAVE 25% PER PERSON WHEN REGISTERING FOUR For every three simultaneous registrations from your company, you will receive a fourth complimentary registration to the program (must register 4 at one time). This is a savings of 25% per person.

SAVE 15% PER PERSON WHEN REGISTERING THREE Can only send three? You can still save 15% off of every registration. To find out more on how you can take advantage of these group discounts, please call 866-207-6528.

Make checks payable to ExL Events, Inc. and write code P1123 on your check. You may also use Visa, MasterCard, Discover or American Express. Payments must be received in full prior to the commencement of the conference.

Cancellations: If you need to cancel your registration for an upcoming ExL conference, please note the following policies derived from the Start Date of the event:Four weeks or more: A full refund (minus a $95 processing fee), or a voucher to another ExL event valid for two years from the voucher issue date.Four weeks or Less: A voucher to another ExL event valid for two years from the voucher issue date.*ExLPharma’sliabilityislimitedtotheconferenceregistrationfeeintheeventofacancellation

To receive a refund or voucher, please fax your request to 888-221-6750.

Please Note: Conference registrations may betransferred to other colleagues in the event you are unable to attend. There will be an administrative charge of $300 to substitute, exchange and/or replace attendance badges with a colleague occurring within five business days of any ExL conference.Please notify ExL Pharma, info@exlpharma.com, prior to the event with the name and contact information of the replacement attendee.

PleaseNote:Speakersandagendaaresubjecttochangewithoutnotice.Intheeventofaspeakercancellation,everyefforttofindasuitablereplacementwillbemade.*TheopinionsofthisfacultydonotnecessarilyreflectthoseofthecompaniestheyrepresentorExLEvents,Inc.*

Do you want to spread the word about your organization’s solutions and services to potential clients who will be attending this event? Take advantage of the opportunity to exhibit, present an educational session, host a networking event, or distribute promotional items to attendees. ExL Pharma will work closely with you to customize a package that will suit all of your needs. To learn more about these opportunities, please contact:

STEVE DECKER

Business Development Manager

212-400-6234, sdecker@exlpharma.com

REGISTRATION FEES FOR ATTENDING ExL’S 8th MSL Best Practices Conference

EARLY BIRD PRICINGREGISTER BY FRIDAY, FEBRUARY 25, 2011 FOR EARLY-BIRD PRICING:

CONFERENCE + WORKSHOP | $1995

CONFERENCE ONLY | $1695

STANDARD PRICINGREGISTER AFTER FRIDAY, FEBRUARY 25, 2011:

CONFERENCE + WORKSHOP | $2195

CONFERENCE ONLY | $1895

ONSITE PRICING CONFERENCE + WORKSHOP | $2295

CONFERENCE ONLY | $1995

36OPMTHE FULL SPECTRUM OF PRODUCT MANAGEMENT

36O

MEDIA PARTNERS

SPONSORSHIP & EXHIBITING OPPORTUNITIES

PRE-CONFERENCE WORKSHOP A:

MSL AND MEDICAL AFFAIRS COLLABORATIONImproving Internal Communication between Field-Based MSLs and Office-Based Medical Affairs to Strengthen Scientific Integrity and Therapeutic Area SuccessPAUL WEBER, MD, RPh, MBA, Executive Director, Global Medical Affairs, Medical Disease Lead, CELGENE

PRE-CONFERENCE WORKSHOP B:

MSL TRAINING STANDARDSDeveloping the Skills and Core Competencies of MSLs to Enhance Team PerformancePAUL MINNE, PharmD, RPH, Senior Regional Medical Liaison Metabolic Bone, AMGENDENISE PITNER, PharmD, Therapeutic Team Director, NOVARTISCRAIG KLINGER, RPh, Senior Medical Liaison Consultant, ELI LILLY & CO.

DISTINGUISHED SPEAKERS JOIN US FROM:

A P R I L 1 4 - 1 5 , 2 0 1 1 | D O L C E | B A S K I N G R I D G E | N E W J E R S E Y

8th MSL BEST PRACTICES

ACTELION PHARMACEUTICALS, US

AMGEN

BAYER HEALTHCARE

BOEHRINGER

INGELHEIM

CELGENE

ELI LILLY & CO.

EISAI

GENZYME

IKARIA

MCGUIREWOODS

NOVARTIS

OPENQ

SHIRE

WITHIN3

ZIPHER MEDICAL AFFAIRS, LLC

SPONSORED BY:

REGISTER TODAY . . . www.exlpharma.com/8thmslMENTION PRIORITY CODE P1123

ExL Events, Inc.555 8th Avenue, Suite 310New York, NY 10018

866-207-6528

888-221-6750

registration@exlpharma.com

www.exlpharma.com/8thmsl

Yes! Register me for the conference and workshop A Yes! Register me for the conference and workshop B

Yes! Register me for the conference only

Please contact me: I’m interested in marketing opportunities at this event I wish to receive email updates on ExL Pharma’s upcoming events

Name: Title:

Company:

Dept.:

Address:

City: State: Zip:

Email:

Telephone: Fax:

Method of Payment: Check Credit Card Make checks payable to ExL Events, Inc.Card Type: MasterCard Visa Discover Amex

Card Number: Exp. Date:

Name on Card:

Signature:

555 8th Avenue, Suite 310New York, NY 10018PRIORITY CODE: P1123